Amel Tounsi
Chief Executive Officer bij Bridge2Health SA
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Laurent Burton | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 22 jaar |
Laurent Levy | M | - |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | 10 jaar |
Gaëtan Servais | M | 56 |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 16 jaar |
Patrick Stragier | M | - |
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium.
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 9 jaar |
Joel Plumas | M | - |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | 10 jaar |
Marc Foidart | M | - |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium.
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 9 jaar |
Géraldine Massart | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 18 jaar |
Mondher Mahjoubi | M | 65 |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | - |
Douglas Geddes | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 4 jaar |
Pierre Vandepapeliere | M | - |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | - |
Eric Halioua | M | - |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | 8 jaar |
Francis Lambert | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | - |
Christian Homsy | M | 65 | 1 jaar | |
Florent Gros | M | 56 |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | - |
Marie Braun | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 5 jaar |
Eric Brandt | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | - |
Sangwoo Lee | M | 52 |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | 5 jaar |
Stéphanie Crahay | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 16 jaar |
Marleen Johanna Limbourg | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 2 jaar |
Gaëtan Baudelet | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 7 jaar |
Louis Breuls de Tiecken | M | - |
Cerhum SA
Cerhum SA Medical SpecialtiesHealth Technology Cerhum SA engages in the manufacture of dental equipment and supplies. Its products include MyBone and technical ceramics. It offers bone graft and dental printing, ceramic and plastic prototyping, small series production, three dimensional scanning services. The company was founded by Grégory Nolens and Caroline Remacle in 2015 and is headquartered in Liege, Belgium. | - |
Hugues Wallemacq | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 4 jaar |
Bertrand Joiret | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 5 jaar |
Laurence Rosa | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 5 jaar |
Thomas Chevau | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 5 jaar |
Gérôme Vanherf | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | - |
Alain Balthazart | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 3 jaar |
Gaëtan Gottschalk | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 4 jaar |
Hugues Danze | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 5 jaar |
Dimitri Liquet | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 6 jaar |
Axel Champenois | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 2 jaar |
Mélanie Merche | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | - |
Julie Gaspard | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 7 jaar |
Gustave Moonen | M | - |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium. | - |
Joanna Tyrekidis | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 9 jaar |
Jean-Paul Prieels | M | 78 |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | - |
Kenneth A. Buckfire | M | - |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | - |
Fabian Marcq | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 24 jaar |
Stéphane Dumoulin | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 17 jaar |
François Fontaine | M | - |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | - |
Michel Morant | M | - |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium. | - |
Christine Gerardy | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | - |
Philippe Degive | M | - |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium. | - |
Michèle Detaille | F | 66 |
Université Catholique de Louvain
| 19 jaar |
Valérie Gordenne | F | 51 | 3 jaar | |
Julien Compere | M | - |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium. | - |
Frédéric Driessens | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 5 jaar |
Alain Herrera | M | 74 |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | - |
Valérie Calenda | M | - |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | - |
Xavier Péters | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 10 jaar |
Jean Javaux | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 11 jaar |
Benoit Fellin | M | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 15 jaar |
Jacques Galloy | M | 53 | 1 jaar | |
Jacques Boniver | M | - |
Bridge2Health SA
Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium. | - |
Inge Beernaert | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
François Fornieri | M | - | 23 jaar | |
Patricia van Dijck | M | 59 | - | |
Ajit Shetty | M | 77 | - | |
Steven de Gryze | M | - |
Université Catholique de Louvain
| 11 jaar |
Christian Moretti | M | 78 | 2 jaar | |
Erik van den Eynden | M | 56 | 2 jaar | |
Liesbeth Weynants | F | 53 | 2 jaar | |
An Cloet | F | 53 | 2 jaar | |
Nicolas Roberti de Winghe | M | - |
Université Catholique de Louvain
| 5 jaar |
Helena Beltran-Lopez | M | - |
Université Catholique de Louvain
| 6 jaar |
Koen Vervaeke | M | - |
Université Catholique de Louvain
| 5 jaar |
Xavier de Villepin | M | - |
Université Catholique de Louvain
| 6 jaar |
Benjamin Cox | M | - |
Université Catholique de Louvain
| 4 jaar |
François Schaus | M | - |
Université Catholique de Louvain
| 3 jaar |
Jonathan Graas | M | - |
Université Catholique de Louvain
| 4 jaar |
Fabrice Quinet | M | - |
Université Catholique de Louvain
| 1 jaar |
Thomas Ykman | M | - |
Université Catholique de Louvain
| 4 jaar |
Olivier Potvin | M | - |
Université Catholique de Louvain
| 3 jaar |
Francois Xavier-Fanard | M | - |
Université Catholique de Louvain
| 5 jaar |
Gregoire Dupuis | M | - |
Université Catholique de Louvain
| 2 jaar |
Maud Vanderthommen | F | - | 4 jaar | |
Adrian De Greve | M | - |
Université Catholique de Louvain
| 4 jaar |
Kristof van Overloop | M | - |
Université Catholique de Louvain
| 4 jaar |
Quentin Adam | M | - |
Université Catholique de Louvain
| 5 jaar |
Frederic Albert G Lammens | M | - |
Université Catholique de Louvain
| 6 jaar |
Jean-Pascal Duvieusart | M | 57 |
Université Catholique de Louvain
| 1 jaar |
Leon van Rompay | M | 75 | - | |
Wim Claes | M | - |
Université Catholique de Louvain
| 3 jaar |
David Solomon | M | 63 | 1 jaar | |
Noël Jans | M | - |
Université Catholique de Louvain
| 1 jaar |
Carole Monterrat | M | - |
Université Catholique de Louvain
| 2 jaar |
Patrick Zurstrassen | M | 79 |
Université Catholique de Louvain
| - |
Giulia van Waeyenberge | F | 42 |
Université Catholique de Louvain
| 1 jaar |
Patrick Monaco-Sorge | M | - |
Université Catholique de Louvain
| 3 jaar |
Elaine Shen | M | - |
Université Catholique de Louvain
| 3 jaar |
Nathalie Omin | F | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | 8 jaar |
Jean-Francois Burguet | M | - |
Université Catholique de Louvain
| 3 jaar |
Ricardo Molano León | M | - |
Université Catholique de Louvain
| 3 jaar |
Benoît Mathieu | M | - | 2 jaar | |
Gotti-Tedeschi Federico | M | - |
Université Catholique de Louvain
| 2 jaar |
Yu Yang | M | 42 |
Université Catholique de Louvain
| 1 jaar |
Olivier Banneux | M | - |
Université Catholique de Louvain
| 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
België | 89 | 91.75% |
Frankrijk | 8 | 8.25% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Amel Tounsi
- Persoonlijk netwerk